NHLBI's Trans-Omics for Precision Medicine (TOPMed) Program
Mollie A. Minear, PhD1; Meagan Grant, PhD1,2; Marie-Luise Brennan, MD, PhD1,3; Hwaida Hannoush, MD1,3; James Luo, PhD1; Julie L. Mikulla, MSc, RN1; Pankaj Qasba, PhD1; Jonathan R. Kaltman, MD1; Alastair Thomson1; Sarah C. Nelson, PhD4; Kenneth M. Rice, PhD4; Gonçalo R. Abecasis, PhD5; Thomas W. Blackwell, PhD5; Albert V. Smith, PhD5; and Weiniu Gan, PhD1 on behalf of the TOPMed Consortium6
1 National Heart, Lung, and Blood Institute (NHLBI), Bethesda, MD;
2 AAAS Science & Technology Policy Fellow, Washington, DC;
3 American College of Medical Genetics and Genomics, Bethesda, MD;
4 University of Washington, Seattle, WA;
5 University of Michigan, Ann Arbor, MI;
6 A full list of TOPMed Consortium members can be found at: https://www.nhlbiwgs.org/topmed-banner-authorship